LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA

被引：1
|
作者：
Harrigan, K. [1 ]
Walton, S. M. [1 ]
Huang, S. P. [1 ]
Kumar, V. M. [2 ]
Chapman, R. H. [2 ]
Atlas, S. J. [3 ]
Agboola, F. O. [2 ]
Ollendorf, D. A. [2 ]
Touchette, D. R. [1 ]
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Inst Clin & Econ Review, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1257
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH29
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia
    Ganz, Michael L.
    Chavan, Ameya
    Dhanda, Rahul
    Serbin, Michael
    Yonan, Charles
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 103 - 113
  • [2] Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia (vol 24, pg 103, 2020)
    Ganz, M. L.
    Chavan, A.
    Dhanda, R.
    Serbin, M.
    Yonan, C.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1108 - 1108
  • [3] A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
    Patel, Rikinkumar S.
    Mansuri, Zeeshan
    Motiwala, Fatima
    Saeed, Hina
    Jannareddy, Namrata
    Patel, Hiren
    Zafar, Muhammad Khalid
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2019, 9
  • [4] Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Singer, Carlos
    Comella, Cynthia
    Marder, Stephen
    Farahmand, Khodayar
    Jimenez, Roland
    [J]. NEUROLOGY, 2020, 94 (15)
  • [5] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (01) : 3 - 3
  • [6] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. CNS SPECTRUMS, 2023, 28 (02) : 241 - 241
  • [7] A long-term, open-label study of valbenazine for tardive dyskinesia
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Marder, Stephen R.
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace S.
    O'Brien, Christopher F.
    [J]. CNS SPECTRUMS, 2021, 26 (04) : 345 - 353
  • [8] Long-term effects of valbenazine on tardive dyskinesia in patients with a mood disorder
    McIntyre, R.
    Nierenberg, A.
    Farahmand, K.
    Burke, J.
    Siegert, S.
    [J]. BIPOLAR DISORDERS, 2018, 20 : 116 - 116
  • [9] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farah-Mand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 345
  • [10] Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROLOGY, 2023, 100 (17)
12345